Cognito Therapeutics raised $105 million in Series C funding led by Morningside Ventures to advance its Spectris platform for Alzheimer’s disease.
- Amount
- $105M
- Stage
- Series C
- Announced
- 6 March 2026
- Lead
- Morningside Ventures
- Use of funds
- Advance Spectris Platform for Alzheimer's
- Checked
- Amount and date checked against the press source